about
Limb malformations and the human HOX genesGastrointestinal involvement in Fabry disease. So important, yet often neglected.Angiokeratomas of Fabry successfully treated with intense pulsed light.[Globosides as key players in the pathophysiology of Shiga toxin-associated acute kidney failure and Fabry disease].Depletion of globosides and isoglobosides fully reverts the morphologic phenotype of Fabry diseaseEnzyme replacement therapy and beyond-in memoriam Roscoe O. Brady, M.D. (1923-2016).Fabry's disease. A brief review in connection with a Scandinavian survey.Fabry disease: recent advances in enzyme replacement therapy.Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities.Past and future: porphyria and porphyrins.Long-term effect of enzyme replacement therapy with fabry diseaseNewborn screening for lysosomal storage disorders.Fabry disease, enzyme replacement therapy and the significance of antibody responses.Difficulties and barriers in diagnosing Fabry disease: what can be learnt from the literature?Multimodality imaging for pre-clinical assessment of Fabry's cardiomyopathy.Perspectives in Pediatric Pathology, Chapter 21. Testicular Pathology in Heritable Metabolic Disease.Fabry's disease: an example of cardiorenal syndrome type 5.Characterization and phosphoproteomic analysis of a human immortalized podocyte model of Fabry disease generated using CRISPR/Cas9 technology.Professor Sir Thomas McCall Anderson (1836-1908).Angiokeratoma corporis diffusum in a patient with Hodgkin lymphoma: a new paraneoplastic skin manifestation?Clinical-Pathological Conference Series from the Medical University of Graz : Case No 153: A 55-year-old woman with atypical multiple sclerosis and irritable bowel syndrome.Pathomechanisms of renal Fabry disease.Fabry's disease: otoneurologic findings in twelve members of one family.Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice.Fabry disease: a morphologic study of 11 cases.Quantitative dysmorphology assessment in Fabry disease.
P2860
Q28204788-429E88F6-EBF0-453C-8FDF-ADD2ED81EA5CQ30991194-66E52C1D-4F2B-440E-99B7-A0353AF90A2AQ33373387-24100DE8-1BD2-42B5-AA4D-54E8189000F7Q33418419-7EB18AA0-37C4-497A-B23D-126EC79289D0Q34294988-B98EE228-D33B-4245-B1A3-CCAEA25D54D2Q34553589-99630191-8ABC-4244-95CF-F02D1647F15CQ34586506-2170FCC0-BC7F-4F39-8785-6DB13EB75FC7Q34974879-27329E15-F2E9-43E5-A231-6E405BDD3982Q34981327-A1E937F1-457B-4332-9217-9F1F033A08E5Q35635580-20FEB464-BE31-4874-98FD-D6CB19E1C907Q36311271-4BFF3CB9-C792-44A2-9A66-8E6A7AC2A094Q37280238-72F28948-B196-4C50-9FAE-388F79311A37Q37839905-042ACFBE-F4DF-477A-97F7-766A5EF5E00BQ37950838-3F62006C-0155-42C2-B1BB-CB81A838B0E3Q38152826-95267B61-E146-4723-A921-91484BA6BAC4Q38218073-126E8835-8FF2-40DD-B691-60D09931F7EEQ38264149-CA1BE0DC-B477-45BD-B3B2-1C761B16C3ADQ38558725-8A103600-BBB2-4008-BA73-B0024FA54F60Q38743299-83EA6B6C-E23E-4261-A8C3-9625125E5FB9Q43528032-A3B67AA4-97C4-42A8-A37B-3404B6FC8FD9Q45067973-1CAFF2DB-D786-4DA8-8828-2043513BD911Q47209693-22B7BAB2-F8DA-462E-AC58-F9D919FB38B6Q48287690-0F358E4B-94D1-4C20-8623-833EE53F4EE5Q50463741-10CC9AF7-83E9-4881-8CFB-F366AA27500DQ51797150-38AC8C71-5C74-4578-9B4B-E5A1845D66BAQ51798460-7C78EAC2-5937-4481-9796-A0449D68ED24Q52025819-76B73810-8782-4717-B3BF-3A751DDCFBB3
P2860
description
article
@en
im April 1898 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 1898
@uk
ലേഖനം
@ml
name
A CASE OF “ANGEIO-KERATOMA.”
@en
A CASE OF “ANGEIO-KERATOMA.”
@nl
type
label
A CASE OF “ANGEIO-KERATOMA.”
@en
A CASE OF “ANGEIO-KERATOMA.”
@nl
prefLabel
A CASE OF “ANGEIO-KERATOMA.”
@en
A CASE OF “ANGEIO-KERATOMA.”
@nl
P1476
A CASE OF “ANGEIO-KERATOMA.”
@en
P2093
WILLIAM ANDERSON
P304
P356
10.1111/J.1365-2133.1898.TB16317.X
P407
P577
1898-04-01T00:00:00Z